Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205590 | SCV000261900 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173860 | SCV001336976 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001657995 | SCV001873869 | likely benign | not provided | 2021-11-18 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Prevention |
RCV003417750 | SCV004117468 | uncertain significance | DYNC1H1-related disorder | 2023-04-21 | criteria provided, single submitter | clinical testing | The DYNC1H1 c.7539G>C variant is predicted to result in the amino acid substitution p.Glu2513Asp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0026% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-102482751-G-C). This variant is classified as likely benign/uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/220931/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |